跳至主要内容
临床试验/EUCTR2021-003821-31-SE
EUCTR2021-003821-31-SE进行中(未招募)1 期

Patient-controlled Sedation in Port Implantation (PACSPI 2)- a randomized controlled trial

Region Jönköping, Sweden0 个研究点目标入组 340 人开始时间: 2022年1月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
340

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult patients (=18 years) with cancer scheduled for SVP-implantation at participating anaesthesia departments.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 170
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 170

排除标准

  • Inability to operate the PCS apparatus,
  • Inability to communicate in Scandinavian languages.
  • Patients who require general anaesthesia or patients eligible for LA only on anesthesiologist´s assessment (i.e. severe sleep apnea).
  • Propofol or alfentanil allergy.
  • Non-fasting according to guidelines of the Swedish Society for Anaesthesia and Intensive Care (SFAI).
  • Failure to achieve peripheral vascular access.
  • Previous participation in study
  • All exclusion criteria as per implantation team´s assessment.

研究者

发起方
Region Jönköping, Sweden

相似试验